APA (7th ed.) Citation

LH, T., AN, B., HI, K., TD, D., A, W., TM, T., . . . JS, L. (2026). Evaluation of the vaccine candidate ASFV-MEC-01: Safety, efficacy, transmission dynamics, and assessment of reversion to virulence. Emerging microbes & infections, 15(1), 2608395. https://doi.org/10.1080/22221751.2025.2608395

Chicago Style (17th ed.) Citation

LH, Tran, et al. "Evaluation of the Vaccine Candidate ASFV-MEC-01: Safety, Efficacy, Transmission Dynamics, and Assessment of Reversion to Virulence." Emerging Microbes & Infections 15, no. 1 (2026): 2608395. https://doi.org/10.1080/22221751.2025.2608395.

MLA (9th ed.) Citation

LH, Tran, et al. "Evaluation of the Vaccine Candidate ASFV-MEC-01: Safety, Efficacy, Transmission Dynamics, and Assessment of Reversion to Virulence." Emerging Microbes & Infections, vol. 15, no. 1, 2026, p. 2608395, https://doi.org/10.1080/22221751.2025.2608395.